Ana Hipólito completed her PhD in Health Sciences in February 2024 at the Nova Medical School, in collaboration with the Portuguese Institute of Oncology of Lisbon Francisco Gentil (IPOLFG). She holds a Master's in Biomedical Research (2018) from the Universidade de Coimbra as well as a Bachelor's in Human Biology (2015) from the Universidade de Évora. Her doctoral research focused on oncobiology and tumor metabolism, particularly in understanding the role of cysteine metabolism in cancer and its potential as a therapeutic target. She has contributed to the development of innovative experimental models and clinical databases, bridging basic research with clinical applications to improve patient outcomes. Her work in tumor microenvironment and metabolic shifts in cancer aggressiveness has led to the identification of new therapeutic targets for melanoma, lung, breast, and colorectal cancers and to the development of a new anti-cancer agent targeting cysteine metabolism. She has published 10 articles in peer-reviewed journals and one book chapter. She has participated in several projects and her research expertise spans medical and health sciences with a focus on translational research and tumor microenvironment.